Work

Impact of Mutational Status on Clinical Response to Imetelstat in Patients with Lower-Risk Myelodysplastic Syndromes in the IMerge Phase 3 Study

Year: 2023

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2023-179378

Authors: Valeria Santini, Amer M. Zeidan, Pierre Fenaux, Yazan F. Madanat, Tymara Berry, Faye M. Feller, Libo Sun, Qi Xia, Ying Wan, Fei Huang, Michael R. Savona, Uwe Platzbecker

Institutions: Azienda Ospedaliero-Universitaria Careggi, University of Florence, Yale Cancer Center, Yale University, Hôpital Saint-Louis, Université Paris Diderot, Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, University Hospital Leipzig

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4389243661

Cites:

Cited by: 2

Related to: 10